Skip to main content

Published locations for FDA advisory panel nixes approval of drug-device for liver metastases

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA advisory panel nixes approval of drug-device for liver metastases

User login

  • Reset your password
  • /content/fda-advisory-panel-nixes-approval-drug-device-liver-metastases
  • /edermatologynews/article/58699/oncology/fda-advisory-panel-nixes-approval-drug-device-liver
  • /internalmedicinenews/article/58699/oncology/fda-advisory-panel-nixes-approval-drug-device-liver
  • /acssurgerynews/article/58699/oncology/fda-advisory-panel-nixes-approval-drug-device-liver-metastases
  • /oncologypractice/article/58699/oncology/fda-advisory-panel-nixes-approval-drug-device-liver
  • /hematology-oncology/article/58699/oncology/fda-advisory-panel-nixes-approval-drug-device-liver
  • /internalmedicine/article/58699/oncology/fda-advisory-panel-nixes-approval-drug-device-liver
  • /dermatology/article/58699/oncology/fda-advisory-panel-nixes-approval-drug-device-liver-metastases
  • /surgery/article/58699/oncology/fda-advisory-panel-nixes-approval-drug-device-liver-metastases